Deutsche Bank
TARS icon

Deutsche Bank’s Tarsus Pharmaceuticals TARS Stock Holding History

Deutsche Bank’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Sell
65,457
-56,405
-46% -$3.6M ﹤0.01% 1477
2026
Q1 		$8.55M Buy
121,862
+3,633
+3% +$254K ﹤0.01% 1107
2025
Q4 		$9.68M Sell
118,229
-66,221
-36% -$4.94M ﹤0.01% 1092
2025
Q3 		$11M Buy
184,450
+82,081
+80% +$4.04M ﹤0.01% 1025
2025
Q2 		$4.15M Sell
102,369
-49,052
-32% -$2.21M ﹤0.01% 1322
2025
Q1 		$7.78M Sell
151,421
-2,020
-1% -$99.9K ﹤0.01% 1084
2024
Q4 		$8.5M Buy
153,441
+74,275
+94% +$3.37M ﹤0.01% 1071
2024
Q3 		$2.6M Buy
79,166
+63,176
+395% +$1.78M ﹤0.01% 1598
2024
Q2 		$435K Buy
15,990
+4,471
+39% +$150K ﹤0.01% 2398
2024
Q1 		$419K Buy
11,519
+468
+4% +$13.8K ﹤0.01% 2438
2023
Q4 		$224K Sell
11,051
-240
-2% -$4.01K ﹤0.01% 2810
2023
Q3 		$201K Buy
11,291
+1,985
+21% +$35.1K ﹤0.01% 2785
2023
Q2 		$168K Sell
9,306
-2,168
-19% -$34.5K ﹤0.01% 2986
2023
Q1 		$144K Buy
11,474
+3,985
+53% +$58.3K ﹤0.01% 3167
2022
Q4 		$110K Buy
7,489
+122
+2% +$2.02K ﹤0.01% 3290
2022
Q3 		$126K Sell
7,367
-1,205
-14% -$19.1K ﹤0.01% 3202
2022
Q2 		$125K Buy
8,572
+3,846
+81% +$57.7K ﹤0.01% 3409
2022
Q1 		$79K Sell
4,726
-961
-17% -$17.8K ﹤0.01% 3666
2021
Q4 		$128K Buy
5,687
+270
+5% +$7.02K ﹤0.01% 3597
2021
Q3 		$116K Sell
5,417
-157
-3% -$3.89K ﹤0.01% 3840
2021
Q2 		$161K Buy
5,574
+1,638
+42% +$51.2K ﹤0.01% 3910
2021
Q1 		$127K Sell
3,936
-378
-9% -$14K ﹤0.01% 3853
2020
Q4 		$178K Buy
+4,314
New +$123K ﹤0.01% 3533

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank's TARS Position: Q2 2026 in Review

Deutsche Bank reduced its Tarsus Pharmaceuticals (TARS) stake by 46% in Q2 2026, selling an estimated $3.6M and leaving 65,457 shares worth $4.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Deutsche Bank first reported a position in TARS in Q4 2020 and has held it in 23 quarters since. The position peaked at $11M in Q3 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Deutsche Bank held 65,457 shares of Tarsus Pharmaceuticals worth $4.12M as of Q2 2026.
  • Deutsche Bank sold 56,405 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $3.6M.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1477 holding.
  • Deutsche Bank first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Deutsche Bank's Tarsus Pharmaceuticals position peaked at $11M in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.